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Introduction 
Cinnamon has been evaluated in clinical studies, including RCTS, for its glycemic-
lowering effects. The studies have been small and produced conflicting results. The objective of 
this paper is to provide an updated systematic review that evaluates the relationship between 
cinnamon supplementation and A1c levels among individuals with Type 2 diabetes mellitus 
(T2DM). 
T2DM, the most common type of diabetes, is a complex metabolic disease characterized 
by high levels of blood glucose. In T2DM, there is an inability of cells to respond normally to 
insulin or an inadequate production of insulin to maintain glucose control. T2DM is a global 
health problem with more than 500 million prevalent cases worldwide, and the incidence is 
increasing around the world1. Those with T2DM have an increased risk for several serious health 
problems, including cardiovascular disease, kidney failure, blindness, limb amputation, 
depression, and cognitive decline3. It is the seventh leading cause of death among adults older 
than 45 years of age in the United States 2. While there is no cure for diabetes, lifestyle 
modifications, drug therapy, and dietary changes are mainstays in management. Medication 
therapy however poses a significant economic burden, with medical costs being twice as high 
compared to those without diabetes2. Other cost-effective strategies that improve glycemic 
control are worth investigating.  
Research has shown that several dietary supplements have similar effects on insulin 
action. Carnation, walnut, green tea, and the spice cinnamon are examples. Cinnamon, because it 
is among the bioactive of these products, has garnered interest for use in hyperglycemic 
conditions, such as T2DM. It has a rich history as a traditional remedy for several ailments and 
has become a natural supplement of interest. Consumption of cinnamon is associated with 
statistically significant reductions in fasting plasma glucose, total cholesterol, LDL-C, and 
triglycerides and an increase in HDL-C levels. The review found no significant effects on A1c 
levels. In a 2017 systematic review of cinnamon supplementation on blood lipid levels, 
significant reductions in blood TGs and total cholesterol were observed without significant 
effects on HDL-C or LDL-C. It has been suggested that cinnamon’s insulin-potentiating effects 
can be attributed to its active component cinnamaldehyde6. Such hypoglycemic effects have been 
investigated in in-vitro and in-vivo trials and demonstrated that cinnamaldehyde enhances 
glucose uptake by activating insulin receptor kinase activity, glycogen synthesis, and 
autophosphorylation of insulin receptors7.  
Several clinical trials have been conducted to explore cinnamon’s efficacy on glucose 
levels; however, they report conflicting results8-13. Consumption of cinnamon doses between 1 to 
6 gram/daily reported reductions in fasting blood glucose (FBG) and in A1c8,10,12,15. However, 
other studies showed that consumption of 1 to 1.2 gram/daily was associated with increases in 
FBG and A1c11. A recent meta-analysis did not reveal any statistically significant changes in 
A1c or fasting blood glucose14. Identifying safe, effective, low cost treatments for hyperglycemia 
in T2DM remains important to help patients on a budget to reach glucose targets.  
Methods 
A systematic review of published studies reporting the effects on blood glucose of 
cinnamon supplementation was conducted following the PRISMA (Preferred Reporting Items for 
Systematic reviews and Meta-Analyses) guidelines. A literature search was conducted in the 
following databases: PubMed and CINHAL. A search strategy was performed to include the 
following combination of keywords: HbA1c, hemoglobin A1c, cinnamon, cinnamonum cassia, 
type 2 diabetes, and diabetes mellitus type 2. Trials that were selected in this systematic review 
were randomized control trials (RCTs)  that evaluated the use of oral cinnamon supplementation 
and reported data on hemoglobin A1c endpoints. Studies that included other endpoint 
parameters, such as lipids and fasting plasma glucose were also included. The data specific to 
HbA1c was then extracted. Study participants were limited to adult subjects. The type of 
cinnamon intervention was limited to the species cinnamomum cassia. Type 2 diabetics, 
excluding those taking insulin, of either gender or age were included. The formulation and 
dosage of cinnamon intervention was not restricted. The search included countries outside of the 
United States. 
Results 
A total of 5 RCTs met the inclusion criteria and were included in the systematic review. 
These 5 RCTs together considered a total of 313 patients who followed the study for a range of 
40 to 90 days. All the RCTs administered cinnamon powder, specifically cinnamomum cassia, 
with the dose ranging from 1 to 6 grams per day. The characteristics of the study participants, 
study characteristics used in RCTs, and results of the selected studies are reported in Table 1, 
Table 2, and Table 3, respectively. 
The results of the first human RCT reported that the addition of 1, 3, or 6 g of cinnamon 
led to significant decreases in serum glucose levels after 40 days. All three doses of cinnamon 
reduced the mean fasting plasma glucose (FPG) ranging from 18 to 29% (Table 3). The response 
to all three levels of cinnamon was similar suggesting that there is no evident dose response. The 
second RCT failed to detect any significant effect in A1c or serum glucose levels after addition 
of 1 g of cinnamon daily for 90 days (Table 3). The third RCT reported that a daily intake of 2 g 
of cinnamon for 12 weeks showed significant reduction in A1c. The fourth RCT suggested that 
intake of 1.5 g of cinnamon per day was associated with reduction in A1c levels (Table 3). The 
fifth RCT was unable to recommend cinnamon for the treatment of T2DM as it failed to improve 
A1c levels (Table 3).  
Table 1. Characteristics of Participants in included RCTs of systematic review 
Variable Khan et al. Blevins et al. Akilen et al. Tangvarasittichai 
et al. 
Talaei et al. 











Gender M&W M&W M&W M&W M&W 
Time since 
diagnosis 
of DM (y) 
6.73 ± 2.32 
7.10 ± 3.29 
N/A 5.84 ± 4.23 
5.76 ± 4.93 
8.14 ± 2.75 




52.0 ± 6.87 
52.0 ± 5.85 
58.0 
63.6 
54.43 ± 12.53 
54.90 ± 10.14 
56.9 ± 1.2 
57.2 ± 1.11 
56.29 ± 9.49 
57.61 ± 8.70 
Mean BMI N/A 32.0 ± 1.5 
32.5 ± 1.7 
32.13 ± 8.31 
33.36 ± 4.20 
24.7 
24.7 
29.02 ± 5.53 
26.41± 3.06 
 
Table 2. Summary of methodology in included RCTs of systematic review 











Khan et al. 2003 Pakistan 
RCT, 
double-blind 
C. cassia 1, 3, 6 Unknown 40 





C. cassia 1  Wheat flour 90 
Akilen et al. 2010 England 
RCT, 
double-blind 






C. cassia 1.5 Unknown 60 
Talaei et al. 2017 Iran 
RCT, 
double-blind 





Table 3. Results of included RCTs in systematic review 








Khan et al. 
2003 
8.9 ± 2.7 7.1 ± 2.6 12.2 ± 2.3 9.4 ± 2.3 
Blevins et al. 
2007 
7.2 ± 0.3 7.4 ± 0.4 7.1 ± 0.2 7.2 ± 0.4 





8.0 7.6 7.7 8.0 
Talaei et al. 
2017 
10.04 ± 1.30 10.11 ± 1.49 10.31 ± 1.86 10.30 1.70 
 
Discussion 
In this systematic review of studies assessing glycemic control, consumption of cinnamon, 
specifically the cinnamonum cassia formulation, of at least 1 gram daily may reduce HbA1c in 
T2DM patients. When comparing changes in serum glucose to the dosage of supplementation 
given, as in Khan12, a decrease in serum glucose was observed across all three groups. This 
suggests that there is no significant dose response associated with degree of glycemic control. In 
general, cinnamon was well-tolerated, and no side effects were documented. A systematic review 
by Namazi et al17 showed that cinnamon can reduce levels of glucose in serum with no changes 
in other glycemic parameters. However, it was stated that the studies’ high heterogeneity should 
be interpreted lightly.  
A limitation of this analysis is in the quality of the interventions performed. Multiple 
characteristics of the 5 RCTs including gender, age, ethnicity, years of diagnosis of T2DM, 
baseline HbA1c, and baseline BMI were all varied suggesting a degree of heterogeneity 
contributing to the results. Other factors such as diet at baseline or during the experimental 
period were not reported which may have also contributed to the heterogeneity of the results. 
Another limitation is the lack of documentation of compliance to supplementation by pill counts 
was only achieved by one study.  
To conclude, the data suggests that cinnamon supplementation, when used as an adjunct to 
diabetic management, may provide some lowering effects on HbA1c. However, it is not 
recommended as a replacement for hypoglycemic medications, exercise, or proper diet. Given 
the increasing prevalence of T2DM and the economics of our pharmaceutical system, it is within 
reason to consider safe adjuncts, especially if it can help improve glycemic control. For diabetics 
on a tight budget, cinnamon may serve as a cost-effective adjunct to standard therapy to help 
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